Close
Help


Dronedarone in Atrial Fibrillation

Posted Mon, Aug, 12,2013

Published today in Clinical Medicine Insights: Cardiology is a new review by Jordi Heijman, Gerd Heusch and Dobromir Dobrev.  Read more about this paper below:

Title

Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation

Abstract

Atrial fibrillation remains the most common arrhythmia in clinical practice. Dronedarone is an antiarrhythmic drug for the maintenance of sinus rhythm in patients with atrial fibrillation. Dronedarone is an amiodarone derivative developed to reduce the number of extracardiovascular side effects. Dronedarone has undergone extensive experimental and clinical testing during the last decade. On the aggregate, these studies have highlighted a complex set of pleiotropic actions that may contribute to dronedarone’s antiarrhythmic effects. In this review, we summarize the clinical studies that have evaluated dronedarone and provide an overview of dronedarone's electrophysiological and nonelectrophysiological pleiotropic actions.

Click here to learn more about the article, download it and comment

share on

Posted in: Articles Published

  • Efficient Processing: 4 Weeks Average to First Editorial Decision
  • Fair & Independent Expert Peer Review
  • High Visibility & Extensive Database Coverage
Services for Authors
What Your Colleagues Say About Libertas Academica
The review process in Libertas Academica journals is prompt, objective and rigorous.  The entire process is smooth and clear and all the editorial staff are cooperative and professional.  Published papers are of top clinical and scientific value, and high metrics reflect the excellent quality of Libertas Academica's journals.
Dr Antoine Kossaify (USEK NDS University Hospital, Byblos, Lebanon)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube